1. Short title This Act may be cited as the Protecting Life and Integrity in Research Act of 2024 . 2. No research involving human fetal tissue obtained pursuant to an induced abortion (a) In general (1) In general No Federal department, agency, or office may conduct, fund, approve, or otherwise support any research involving human fetal tissue that is obtained pursuant to an induced abortion. (2) Development of new, ethical cell lines Subsection (a) does not limit the authority of the head of any Federal department, agency, or office, to develop or support the development of new, high-efficiency cell lines, including for the production of vaccines and genetic vectors, so long as the cell lines are not derived from human fetal tissue that is obtained pursuant to an induced abortion. (3) Research involving human fetal tissue obtained after a miscarriage or stillbirth permitted Any research of any Federal department, agency, or office on human fetal tissue obtained after a miscarriage or stillbirth shall be conducted or supported in accordance with section 498A of the Public Health Service Act ( 42 U.S.C. 289g–1 ). (4) Definition In this subsection, the term human fetal tissue has the meaning given such term in section 498A(g) of the Public Health Service Act ( 42 U.S.C. 289g–1(g) ). (b) Amendments to the PHSA limiting human fetal tissue research to tissue obtained after a miscarriage or stillbirth Section 498A of the Public Health Service Act ( 42 U.S.C. 289g–1 ) is amended— (1) in the section heading, by striking transplantation of fetal tissue and inserting human fetal tissue obtained after a miscarriage or stillbirth ; (2) by amending subsection (a) to read as follows: (a) Establishment of program The Secretary may conduct or support research on human fetal tissue obtained after a miscarriage or a stillbirth. ; (3) in subsection (b)— (A) in paragraph (1)(B), by inserting if the human fetal tissue is intended for transplantation, before the donation ; and (B) in paragraph (2)— (i) by striking subparagraph (A)